In a recent interview at the RSNA conference, Raj Chopra, MD shared his insights on the continued rise of cyberattacks, the impact of these attacks in radiology and keys to prevention and effectively responding to such events.
Cybersecurity continues to be a daunting challenge in health care. In the first half of 2024, 387 data breaches involving 500 or more health-care records were reported to the United States Department of Health and Human Services (HHS)’s Office for Civil Rights.1
While a 2023 survey revealed that 63 percent of radiologists received cybersecurity training, only 38 percent of respondents felt confident after the training.2
In a recent interview at the RSNA conference, Raj Chopra, M.D., the chief medical officer of Merge by Merative, discussed his own experience dealing with a cyberattack that led to turmoil, delays and frustration at multiple practices, and an unresponsive security vendor.
“The vendor that was working with us decided to turtle up. The communication just stopped, which means all the frustration came on us as the clinicians and the radiologists, and it was a light bulb moment (that we needed) a better plan internally to deal with when cyberattacks occur,” recalled Dr. Chopra. “But we also need the vendors to provide a platform where we can communicate with them and trust them that they're working on the solution so twe can say that information to patients, to staff and the (referring) clinicians that are out there.”
(Editor’s note: For additional coverage from the RSNA conference, click here.)
Dr. Chopra emphasized that radiology is a key target for criminals so diligence in following cybersecurity protocols and communication are pivotal in preventing and responding to cyberattacks. He used the analogy of a California utility company’s response when electrical power is lost.
“They'll tell you (with) step one that there is a problem. They'll tell you with step two that they're working on the problem. Step three, they'll tell you that they have professionals at the site trying to figure out what's going on. Then they give you an estimate of time. Once that estimate of time is getting close to reach, they give you an update, and at the end of that update, they tell you that you're going to be up and running. We as a health care community need to do that too,” noted Dr. Chopra.
(Editor’s note: For related content, see “Five Solutions to Address Cybersecurity Challenges in Radiology,” “Cyberattacks: What Radiology IT Departments Must Do Now” and “How the Convergence of AI and the Cloud Can Unlock Breakthroughs and Cost Savings in Radiology.”)
For more insights from Dr. Chopra, watch the video below.
References
1. Adler S. H1, 2024 healthcare data breach report. HIPAA Journal. Available at: https://www.hipaajournal.com/h1-2024-healthcare-data-breach-report/ . Published July 30, 2024. Accessed December 11, 2024.
2. Merative. 2023 Merge cloud survey. Available at: https://www.merative.com/documents/analyst-report/cloud-survey-report-2023 . Accessed December 11, 2024.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
SNMMI: Can Multimodal Monitoring Bolster Outcomes with Pluvicto in Treating mCRPC?
June 22nd 2025Multimodal treatment monitoring, including SPECT/CT exams 24 hours after treatment with Lu-177 PSMA-617, may have facilitated significantly shorter therapy durations and reduced side effects in patients with mCRPC, according to a two-year study presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.